• Explore /
  • Poster
  • / <span>Preliminary antitumor activity of the combination of COM701 + BMS-986207 + nivolumab in patients with recurrent, metastatic MSS endometrial cancer.</span>

Preliminary antitumor activity of the combination of COM701 + BMS-986207 + nivolumab in patients with recurrent, metastatic MSS endometrial cancer.

Abstract Poster

Authors

null

Drew W. Rasco

START San Antonio, San Antonio, TX

Drew W. Rasco , Daniel A. Vaena , Gini F. Fleming , Ecaterina Elena Dumbrava , Oladapo O. Yeku , Manish Sharma , Kyriakos P. Papadopoulos , Ryan J. Sullivan , Stephanie Gaillard , Adeboye H. Adewoye , John William Moroney

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Uterine Cancer

Clinical Trial Registration Number

NCT04570839.

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5595)

DOI

10.1200/JCO.2023.41.16_suppl.5595

Abstract #

5595

Poster Bd #

290

Abstract Disclosures

Similar Posters

First Author: Manish Sharma

First Author: Shipra Gandhi

First Author: Elizabeth Katherine Lee

First Author: B.J. Rimel